Furthermore, circulating PLA2G7 levels progressively rise during cachexia development and are already increased in pre‐cachectic tumour‐bearing animals, suggesting that PLA2G7 could be an early marker of the disease (i.e. before onset of body weight loss). This evidence concerns the gene PLA2G7 and neoplasm.